These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 28470517)
1. A Protocol for In Vitro High-Throughput Chemical Susceptibility Screening in Differentiating NT2 Stem Cells. Menzner AK; Gilbert DF Methods Mol Biol; 2017; 1601():61-70. PubMed ID: 28470517 [TBL] [Abstract][Full Text] [Related]
2. Towards in vitro DT/DNT testing: Assaying chemical susceptibility in early differentiating NT2 cells. Menzner AK; Abolpour Mofrad S; Friedrich O; Gilbert DF Toxicology; 2015 Dec; 338():69-76. PubMed ID: 26498558 [TBL] [Abstract][Full Text] [Related]
3. Phenotyping Cellular Viability by Functional Analysis of Ion Channels: GlyR-Targeted Screening in NT2-N Cells. Kuenzel K; Mofrad SA; Gilbert DF Methods Mol Biol; 2017; 1601():205-214. PubMed ID: 28470528 [TBL] [Abstract][Full Text] [Related]
4. Human Ntera2 cells as a predictive in vitro test system for developmental neurotoxicity. Stern M; Gierse A; Tan S; Bicker G Arch Toxicol; 2014 Jan; 88(1):127-36. PubMed ID: 23917397 [TBL] [Abstract][Full Text] [Related]
5. Optimizing neuronal differentiation of human pluripotent NT2 stem cells in monolayer cultures. Abolpour Mofrad S; Kuenzel K; Friedrich O; Gilbert DF Dev Growth Differ; 2016 Oct; 58(8):664-676. PubMed ID: 27671506 [TBL] [Abstract][Full Text] [Related]
6. An in vitro developmental neurotoxicity screening assay for retinoic acid-induced neuronal differentiation using the human NT2/D1 cell line. Taylor MA; Kan HL; Gollapudi BB; Marty MS Neurotoxicology; 2019 Jul; 73():258-264. PubMed ID: 30980846 [TBL] [Abstract][Full Text] [Related]
7. An automated and high-throughput-screening compatible pluripotent stem cell-based test platform for developmental and reproductive toxicity assessment of small molecule compounds. Witt G; Keminer O; Leu J; Tandon R; Meiser I; Willing A; Winschel I; Abt JC; Brändl B; Sébastien I; Friese MA; Müller FJ; Neubauer JC; Claussen C; Zimmermann H; Gribbon P; Pless O Cell Biol Toxicol; 2021 Apr; 37(2):229-243. PubMed ID: 32564278 [TBL] [Abstract][Full Text] [Related]
8. A Protocol for a High-Throughput Multiplex Cell Viability Assay. Gilbert DF; Boutros M Methods Mol Biol; 2016; 1470():75-84. PubMed ID: 27581285 [TBL] [Abstract][Full Text] [Related]
9. Stem Cell-Derived Immature Human Dorsal Root Ganglia Neurons to Identify Peripheral Neurotoxicants. Hoelting L; Klima S; Karreman C; Grinberg M; Meisig J; Henry M; Rotshteyn T; Rahnenführer J; Blüthgen N; Sachinidis A; Waldmann T; Leist M Stem Cells Transl Med; 2016 Apr; 5(4):476-87. PubMed ID: 26933043 [TBL] [Abstract][Full Text] [Related]
10. The DNT-EST: a predictive embryonic stem cell-based assay for developmental neurotoxicity testing in vitro. Hayess K; Riebeling C; Pirow R; Steinfath M; Sittner D; Slawik B; Luch A; Seiler AE Toxicology; 2013 Dec; 314(1):135-47. PubMed ID: 24096155 [TBL] [Abstract][Full Text] [Related]
11. Fingerprinting of neurotoxic compounds using a mouse embryonic stem cell dual luminescence reporter assay. Colaianna M; Ilmjärv S; Peterson H; Kern I; Julien S; Baquié M; Pallocca G; Bosgra S; Sachinidis A; Hengstler JG; Leist M; Krause KH Arch Toxicol; 2017 Jan; 91(1):365-391. PubMed ID: 27015953 [TBL] [Abstract][Full Text] [Related]
12. Sensitivity of neuroprogenitor cells to chemical-induced apoptosis using a multiplexed assay suitable for high-throughput screening. Druwe I; Freudenrich TM; Wallace K; Shafer TJ; Mundy WR Toxicology; 2015 Jul; 333():14-24. PubMed ID: 25841707 [TBL] [Abstract][Full Text] [Related]
13. miRNA expression profiling in a human stem cell-based model as a tool for developmental neurotoxicity testing. Pallocca G; Fabbri M; Sacco MG; Gribaldo L; Pamies D; Laurenza I; Bal-Price A Cell Biol Toxicol; 2013 Aug; 29(4):239-57. PubMed ID: 23903816 [TBL] [Abstract][Full Text] [Related]
14. Novel culture strategy for human stem cell proliferation and neuronal differentiation. Serra M; Leite SB; Brito C; Costa J; Carrondo MJ; Alves PM J Neurosci Res; 2007 Dec; 85(16):3557-66. PubMed ID: 17868148 [TBL] [Abstract][Full Text] [Related]
15. A Recombinant Human Pluripotent Stem Cell Line Stably Expressing Halide-Sensitive YFP-I152L for GABAAR and GlyR-Targeted High-Throughput Drug Screening and Toxicity Testing. Kuenzel K; Friedrich O; Gilbert DF Front Mol Neurosci; 2016; 9():51. PubMed ID: 27445687 [TBL] [Abstract][Full Text] [Related]
16. A high-throughput screen for teratogens using human pluripotent stem cells. Kameoka S; Babiarz J; Kolaja K; Chiao E Toxicol Sci; 2014 Jan; 137(1):76-90. PubMed ID: 24154490 [TBL] [Abstract][Full Text] [Related]
17. Comparison of PC12 and cerebellar granule cell cultures for evaluating neurite outgrowth using high content analysis. Radio NM; Freudenrich TM; Robinette BL; Crofton KM; Mundy WR Neurotoxicol Teratol; 2010; 32(1):25-35. PubMed ID: 19559085 [TBL] [Abstract][Full Text] [Related]
18. microRNA Profiling as Tool for Developmental Neurotoxicity Testing (DNT). Smirnova L; Seiler AEM; Luch A Curr Protoc Toxicol; 2015 May; 64():20.9.1-20.9.22. PubMed ID: 26344224 [TBL] [Abstract][Full Text] [Related]
20. A human pluripotent carcinoma stem cell-based model for in vitro developmental neurotoxicity testing: effects of methylmercury, lead and aluminum evaluated by gene expression studies. Laurenza I; Pallocca G; Mennecozzi M; Scelfo B; Pamies D; Bal-Price A Int J Dev Neurosci; 2013 Nov; 31(7):679-91. PubMed ID: 23501475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]